Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Pain, Postoperative 19Breast Neoplasms 16Pain 9Agnosia 8Lung Neoplasms 6Prostatic Neoplasms 5Neoplasms 5Stomach Neoplasms 4Colorectal Neoplasms 4Postoperative Complications 3Colonic Neoplasms 3Supratentorial Neoplasms 2Meningioma 2Uterine Cervical Neoplasms 1Urinary Bladder Neoplasms 1Thyroid Neoplasms 1Sleep Deprivation 1Sarcoma 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Pancreatic Neoplasms 1Pancreatic Ductal Adenocarcinoma 1Pain, Intractable 1Ovarian Neoplasms 1Ovarian Cysts 1Oropharyngeal Neoplasms 1Neuroblastoma 1Neoplasm Metastasis 1Malignant Neoplasms of Male Genital Organs 1Liver Neoplasms 1Liver Diseases 1

Interventions

Gemcitabine 157Cisplatin 117pembrolizumab 81Cystectomy 46Nivolumab 42Carboplatin 42Paclitaxel 41Mitomycin 41Docetaxel 39atezolizumab 33Magnetic Resonance Spectroscopy 33Radiotherapy 31durvalumab 30avelumab 26BCG Vaccine 26Specimen Handling 25Cystoscopy 24enfortumab vedotin 23Doxorubicin 23Fluorouracil 20Methotrexate 17Vinblastine 16Standard of Care 15Ipilimumab 14Filgrastim 145-aminolevulinic acid hexyl ester 14Transurethral Resection of Bladder 13Surgical Procedures, Operative 13Sunitinib 13Biopsy 13

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Urinary Bladder Neoplasms × Ropivacaine × Clear all
NCT02438852 2019-04-16

Continuous Infusion of Ropivacaine Hydrochloride in Reducing Pain After Surgery in Patients With Bladder Cancer

University of Southern California

Phase 3 Withdrawn
Genitourinary

Urinary Bladder Neoplasms, Pain, Postoperative

Data powered by HemOnc (CC BY 4.0) Colophon âš¡